COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience

Medical Student, University of Missouri-Columbia, Columbia, Missouri. Assistant Professor of Clinical Medicine, Medical Director, Outpatient Parenteral Antimicrobial Therapy (OPAT) and Vascular Access, and Medical Director, HIV/AIDS Program, University of Missouri-Columbia, Columbia, Missouri.

Missouri medicine. 2021;118(1):74-80
Full text from:
Abstract
Convalescent plasma is an old treatment for a new disease. The coronavirus disease 2019 (COVID-19) pandemic caused the analysis of convalescent plasma to reemerge as a possible treatment. First, a systematic review summarizes the available research examining the use of convalescent plasma for the treatment of patients with COVID-19. Second, we describe our experience in establishing a single-center convalescent plasma donation program.
Study details
Study Design : Systematic Review
Language : eng
Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine